MedTrace Logo

Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data

NCT06229405 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 8200

Last updated 2024-03-04

No results posted yet for this study

Summary

This research aims to establish clinical evidence for optimal treatment guidelines for adrenal diseases using real-world data. The approach involves building prospective and retrospective patient registries, which will be utilized to develop and conduct research on disease-specific protocols for adrenal disorders. The study targets patients with primary aldosteronism, pheochromocytoma, adrenal cancer, adrenal incidentalomas, and mild autonomous cortisol secretion. Registries for patients with adrenal diseases will be obtained from Seoul National University Hospital and Asan Medical Center, along with securing a common data model. The ultimate goal is to conduct research to generate clinical evidence for adrenal diseases using these resources.

Conditions

  • Adrenal Tumor
  • Primary Aldosteronism
  • Cushing Syndrome
  • Pheochromocytoma
  • Adrenal Cortical Carcinoma

Sponsors & Collaborators

  • Asan Medical Center

    collaborator OTHER

  • Seoul National University Bundang Hospital

    collaborator OTHER

  • Samsung Medical Center

    collaborator OTHER

  • Inha University Hospital

    collaborator OTHER

  • Chonnam National University Hospital

    collaborator OTHER

  • Nowon Eulji Medical Center

    collaborator UNKNOWN

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Jung Hee Kim, MD, PhD · Seoul National University Hospital

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-10
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06229405 on ClinicalTrials.gov